Eye Doctors in Syosset, NY
After residing in the same location for over 40 years, we have relocated 2.3 miles. Please come see us at our brand new, bigger and beautiful location to better serve our patients and customers. Welcome to Pearle Vision Syosset, where your eye health and wellness is our primary focus. Our services range from routine vision to comprehensive medical eye care, to fitting you with prescription eyeglasses, sunglasses, and contact lenses to meet your individual needs. We offer the latest styles in top brands like Prada, Versace, Oakley, Rayban, Tory Burch, Tiffany and Coach along with contacts from Acuvue and Bausch and Lomb. We fit digitally designed lenses to optimize your prescription to the frame you choose to put it in. Stop in today and let us show you what the eye care experience should be like!
Store info
224 W. Jericho Turnpike, Syosset, NY 11791
- 516-681-2020
Store Hours
| Sun | Closed |
| Mon | 10:00 AM - 6:00 PM |
| Tue | 10:00 AM - 6:00 PM |
| Wed | 10:00 AM - 6:00 PM |
| Thu | 10:00 AM - 6:00 PM |
| Fri | 10:00 AM - 6:00 PM |
| Sat | 10:00 AM - 5:00 PM |
Accepted Insurances
We work with most major health and vision plans.
40% off lenses with frame purchase
Print or show in store to redeem.
Save 40% on lenses with frame purchase. Complete pair (frame and lenses) purchase required. Valid prescription required.
Terms & conditions apply

40% off second pair
Print or show in store to redeem.
Buy a complete pair of eyeglasses or prescription sunglasses (frame and lenses) and get a second pair (same prescription, same day) for up to 40% off.
Terms & conditions applyLearn More
Where to Buy Glasses
Discover MoreHow to Choose an Eye Doctor
Discover MoreHow to Tell if Your Child Needs Glasses
Discover MoreDiscover New Styles
ESSILOR® STELLEST® LENSES
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children
*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6-12 years at initiation of treatment.

















